2 weeks Ago By Defense World Staff
Thermo Fisher Scientific Inc. ( NYSE:TMO – Get Free Report ) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two ratings firms that are covering the stock, Marketbeat.com reports.
Four investment analysts have rated the stock with a hold recommendation, seventeen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $649.33.
Several brokerages have recently weighed in on TMO. Bernstein Bank upped their price objective on shares of Thermo Fisher Scientific from $565.00 to $625.
00 and gave the company a “market perform” rating in a report on Tuesday, October 22nd. Bank of America increased their price target on Thermo Fisher Scientific from $600.00 to $675.
00 and gave the stock a “buy” rating in a report on Monday, September 16th. JPMorgan Chase & Co. upped their target price on Thermo Fisher Scientific from $650.
00 to $670.00 and gave the stock an “overweight” rating in a research report on Friday, September 20th. Robert W.
Baird reduced their price target on shares of Thermo Fisher Scientific from $632.00 to $622.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th.
Finally, Stephens initiated coverage on shares of Thermo Fisher Scientific in a report on Tuesday, October 1st. They set an “overweight” rating and a $680.00 price objective on the stock.
Read Our Latest Analysis on Thermo Fisher Scientific Insider Buying and Selling Hedge Funds Weigh In On Thermo Fisher Scientific Several hedge funds have recently made changes to their positions in the stock. Beaumont Financial Advisors LLC increased its position in shares of Thermo Fisher Scientific by 0.8% during the first quarter.
Beaumont Financial Advisors LLC now owns 2,199 shares of the medical research company’s stock valued at $1,278,000 after buying an additional 17 shares during the period. Cedar Wealth Management LLC increased its holdings in Thermo Fisher Scientific by 14.5% during the 1st quarter.
Cedar Wealth Management LLC now owns 134 shares of the medical research company’s stock worth $78,000 after acquiring an additional 17 shares during the period. Lafayette Investments Inc. grew its position in shares of Thermo Fisher Scientific by 2.
1% during the 2nd quarter. Lafayette Investments Inc. now owns 830 shares of the medical research company’s stock valued at $459,000 after purchasing an additional 17 shares in the last quarter.
IFG Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 3.3% in the third quarter. IFG Advisors LLC now owns 532 shares of the medical research company’s stock worth $329,000 after purchasing an additional 17 shares during the period.
Finally, Patrick M Sweeney & Associates Inc. boosted its stake in Thermo Fisher Scientific by 1.8% during the second quarter.
Patrick M Sweeney & Associates Inc. now owns 1,031 shares of the medical research company’s stock valued at $570,000 after buying an additional 18 shares during the period. 89.
23% of the stock is currently owned by hedge funds and other institutional investors. Thermo Fisher Scientific Trading Down 1.2 % NYSE:TMO opened at $540.
63 on Wednesday. Thermo Fisher Scientific has a 52 week low of $439.11 and a 52 week high of $627.
88. The firm’s fifty day moving average is $592.59 and its 200-day moving average is $583.
56. The firm has a market cap of $206.79 billion, a P/E ratio of 33.
90, a P/E/G ratio of 3.65 and a beta of 0.79.
The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.26 and a current ratio of 1.
63. Thermo Fisher Scientific ( NYSE:TMO – Get Free Report ) last issued its quarterly earnings results on Wednesday, October 23rd. The medical research company reported $5.
28 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.25 by $0.03.
The firm had revenue of $10.60 billion for the quarter, compared to analyst estimates of $10.63 billion.
Thermo Fisher Scientific had a return on equity of 17.49% and a net margin of 14.48%.
The company’s revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.
69 earnings per share. Equities analysts expect that Thermo Fisher Scientific will post 21.69 earnings per share for the current year.
Thermo Fisher Scientific Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Friday, December 13th will be paid a $0.39 dividend.
This represents a $1.56 dividend on an annualized basis and a yield of 0.29%.
The ex-dividend date is Friday, December 13th. Thermo Fisher Scientific’s payout ratio is 9.78%.
About Thermo Fisher Scientific ( Get Free Report Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Featured Stories Five stocks we like better than Thermo Fisher Scientific Golden Cross Stocks: Pattern, Examples and Charts Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 How the NYSE and NASDAQ are Different, Why That Matters to Investors Is Tesla’s Valuation a Bubble or Backed by Real Growth? 3 Small Caps With Big Return Potential Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.
com's FREE daily email newsletter ..
